Vitamin and supplement manufacturer HINNAO has unveiled a new clinical study on glutathione.
HINNAO Glutathione is liquid drops taken under the tongue which use high-stability lipid particles which can be absorbed into the bloodstream through small blood vessels in the mouth.
The company tests all products using independent third-party certified laboratories to verify the percentage of drug permeation at specific time intervals. The study showed that 54% of the HINNAO Glutathione was delivered into the bloodstream within 40 seconds; 80% by 60 seconds and 83% by 90 seconds.
Tania Malan, clinical director at Uniskin, said, “Glutathione has many favourable properties that impact patients’ skin and wellbeing. It is crucial to the immune system, protects the body against oxidative stress while providing immunity to the body. Glutathione has low bioavailability in the body, and the preferred method of supplementation used to be through IV. HINNAO has developed a superior supplementation with a delivery mechanism that equals an infusion. It is less invasive and more cost-effective for patients and clinics, especially those who do not provide infusions.”
You can view the full study here.